Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 4317 | 27.27 |
09:34 ET | 938 | 27.2 |
09:36 ET | 2795 | 27.2 |
09:38 ET | 400 | 27.14 |
09:39 ET | 1627 | 27.18 |
09:41 ET | 1837 | 27.13 |
09:43 ET | 3600 | 27.34 |
09:45 ET | 294 | 27.3606 |
09:48 ET | 2194 | 27.33 |
09:50 ET | 2000 | 27.36 |
09:52 ET | 2053 | 27.34 |
09:54 ET | 479 | 27.32 |
09:56 ET | 700 | 27.31 |
09:57 ET | 700 | 27.27 |
09:59 ET | 3358 | 27.23 |
10:01 ET | 13255 | 27.26 |
10:03 ET | 2443 | 27.255 |
10:06 ET | 3250 | 27.275 |
10:08 ET | 1500 | 27.29 |
10:10 ET | 1100 | 27.33 |
10:12 ET | 2606 | 27.35 |
10:14 ET | 700 | 27.35 |
10:15 ET | 1173 | 27.39 |
10:17 ET | 500 | 27.44 |
10:19 ET | 539 | 27.4138 |
10:21 ET | 805 | 27.405 |
10:24 ET | 1276 | 27.415 |
10:26 ET | 4245 | 27.44 |
10:28 ET | 1545 | 27.485 |
10:30 ET | 100 | 27.48 |
10:32 ET | 941 | 27.47 |
10:33 ET | 1848 | 27.5 |
10:35 ET | 3650 | 27.465 |
10:37 ET | 1968 | 27.47 |
10:39 ET | 1033 | 27.52 |
10:42 ET | 1300 | 27.51 |
10:44 ET | 700 | 27.49 |
10:46 ET | 1307 | 27.49 |
10:48 ET | 2045 | 27.49 |
10:50 ET | 1200 | 27.485 |
10:51 ET | 900 | 27.48 |
10:53 ET | 600 | 27.47 |
10:55 ET | 800 | 27.48 |
10:57 ET | 1913 | 27.47 |
11:00 ET | 1508 | 27.49 |
11:02 ET | 1400 | 27.51 |
11:04 ET | 1006 | 27.53 |
11:06 ET | 500 | 27.51 |
11:08 ET | 4746 | 27.53 |
11:09 ET | 400 | 27.52 |
11:11 ET | 2300 | 27.505 |
11:13 ET | 2747 | 27.53 |
11:15 ET | 600 | 27.53 |
11:18 ET | 4400 | 27.53 |
11:20 ET | 2258 | 27.53 |
11:22 ET | 1863 | 27.53 |
11:24 ET | 1214 | 27.54 |
11:26 ET | 421 | 27.56 |
11:27 ET | 1688 | 27.54 |
11:29 ET | 700 | 27.58 |
11:31 ET | 2103 | 27.59 |
11:33 ET | 700 | 27.6 |
11:36 ET | 3297 | 27.61 |
11:38 ET | 327 | 27.61 |
11:40 ET | 6396 | 27.6 |
11:42 ET | 4037 | 27.61 |
11:44 ET | 1442 | 27.61 |
11:45 ET | 37648 | 27.71 |
11:47 ET | 443 | 27.72 |
11:49 ET | 3841 | 27.84 |
11:51 ET | 3779 | 27.78 |
11:54 ET | 1690 | 27.86 |
11:56 ET | 1849 | 27.815 |
11:58 ET | 1402 | 27.81 |
12:00 ET | 2127 | 27.84 |
12:02 ET | 2500 | 27.85 |
12:03 ET | 9128 | 27.905 |
12:05 ET | 2501 | 27.79 |
12:07 ET | 1270 | 27.69 |
12:09 ET | 1243 | 27.66 |
12:12 ET | 1700 | 27.65 |
12:14 ET | 1501 | 27.67 |
12:16 ET | 2546 | 27.65 |
12:20 ET | 2900 | 27.65 |
12:21 ET | 2980 | 27.648 |
12:23 ET | 1400 | 27.67 |
12:25 ET | 900 | 27.66 |
12:27 ET | 400 | 27.68 |
12:30 ET | 700 | 27.67 |
12:32 ET | 1568 | 27.625 |
12:34 ET | 800 | 27.63 |
12:36 ET | 506 | 27.63 |
12:38 ET | 700 | 27.64 |
12:39 ET | 4144 | 27.62 |
12:41 ET | 2337 | 27.62 |
12:43 ET | 1605 | 27.62 |
12:45 ET | 2441 | 27.62 |
12:48 ET | 1917 | 27.62 |
12:50 ET | 800 | 27.62 |
12:52 ET | 7309 | 27.6 |
12:54 ET | 1370 | 27.615 |
12:56 ET | 3737 | 27.615 |
12:57 ET | 1316 | 27.62 |
12:59 ET | 1543 | 27.65 |
01:01 ET | 800 | 27.67 |
01:03 ET | 3619 | 27.725 |
01:06 ET | 6030 | 27.7 |
01:08 ET | 1333 | 27.655 |
01:10 ET | 1478 | 27.64 |
01:12 ET | 386 | 27.64 |
01:14 ET | 711 | 27.68 |
01:15 ET | 800 | 27.67 |
01:17 ET | 1268 | 27.675 |
01:19 ET | 1055 | 27.67 |
01:21 ET | 1201 | 27.68 |
01:24 ET | 1449 | 27.685 |
01:26 ET | 978 | 27.7 |
01:30 ET | 1195 | 27.72 |
01:32 ET | 1414 | 27.75 |
01:33 ET | 2227 | 27.715 |
01:35 ET | 100 | 27.715 |
01:37 ET | 1487 | 27.7 |
01:39 ET | 708 | 27.68 |
01:42 ET | 100 | 27.68 |
01:44 ET | 950 | 27.68 |
01:46 ET | 800 | 27.67 |
01:48 ET | 721 | 27.67 |
01:50 ET | 1000 | 27.68 |
01:51 ET | 1056 | 27.69 |
01:53 ET | 1699 | 27.68 |
01:55 ET | 1301 | 27.69 |
01:57 ET | 1200 | 27.67 |
02:00 ET | 604 | 27.66 |
02:02 ET | 1494 | 27.65 |
02:04 ET | 700 | 27.65 |
02:06 ET | 4158 | 27.66 |
02:08 ET | 987 | 27.659 |
02:09 ET | 604 | 27.64 |
02:11 ET | 1100 | 27.66 |
02:13 ET | 505 | 27.67 |
02:15 ET | 1600 | 27.68 |
02:18 ET | 200 | 27.68 |
02:20 ET | 2128 | 27.67 |
02:22 ET | 1896 | 27.68 |
02:24 ET | 1427 | 27.67 |
02:26 ET | 3100 | 27.65 |
02:27 ET | 789 | 27.65 |
02:29 ET | 2090 | 27.645 |
02:31 ET | 8095 | 27.64 |
02:33 ET | 3355 | 27.62 |
02:36 ET | 1300 | 27.63 |
02:38 ET | 1578 | 27.63 |
02:40 ET | 3093 | 27.62 |
02:42 ET | 300 | 27.62 |
02:44 ET | 1440 | 27.64 |
02:45 ET | 337 | 27.65 |
02:47 ET | 1500 | 27.67 |
02:49 ET | 6285 | 27.7 |
02:51 ET | 1037 | 27.725 |
02:54 ET | 1492 | 27.71 |
02:56 ET | 212 | 27.71 |
02:58 ET | 980 | 27.72 |
03:00 ET | 4339 | 27.725 |
03:02 ET | 3948 | 27.66 |
03:03 ET | 562 | 27.685 |
03:05 ET | 100 | 27.69 |
03:07 ET | 200 | 27.69 |
03:09 ET | 12970 | 27.64 |
03:12 ET | 7649 | 27.65 |
03:14 ET | 2665 | 27.64 |
03:16 ET | 2200 | 27.635 |
03:18 ET | 2326 | 27.63 |
03:20 ET | 3275 | 27.615 |
03:21 ET | 6730 | 27.595 |
03:23 ET | 3576 | 27.615 |
03:25 ET | 908 | 27.615 |
03:27 ET | 7080 | 27.605 |
03:30 ET | 3263 | 27.605 |
03:32 ET | 2543 | 27.615 |
03:34 ET | 7457 | 27.605 |
03:36 ET | 5822 | 27.595 |
03:38 ET | 6288 | 27.595 |
03:39 ET | 7265 | 27.595 |
03:41 ET | 877 | 27.595 |
03:43 ET | 9749 | 27.615 |
03:45 ET | 12297 | 27.62 |
03:48 ET | 9737 | 27.615 |
03:50 ET | 6504 | 27.625 |
03:52 ET | 12950 | 27.65 |
03:54 ET | 13385 | 27.605 |
03:56 ET | 12055 | 27.56 |
03:57 ET | 20951 | 27.57 |
03:59 ET | 239646 | 27.53 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.6B | 10.3x | --- |
Exelixis Inc | 7.5B | 22.2x | -21.77% |
PTC Therapeutics Inc | 2.6B | -5.9x | --- |
Novavax Inc | 2.2B | -4.8x | --- |
P3 Health Partners Inc | 176.4M | -0.7x | --- |
Medpace Holdings Inc | 10.9B | 31.2x | +35.10% |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.6B |
---|---|
Revenue (TTM) | $1.5B |
Shares Outstanding | 164.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.42 |
EPS | $2.67 |
Book Value | $7.20 |
P/E Ratio | 10.3x |
Price/Sales (TTM) | 3.0 |
Price/Cash Flow (TTM) | 8.9x |
Operating Margin | 24.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.